gene - International Biopharmaceutical Industry

news

Sarepta, with new Duchenne results, to broach ‘possibility’ of speedy gene therapy approval

Dive Brief: Sarepta Therapeutics on Monday presented new results from a placebo-controlled study of its experimental gene therapy for Duchenne muscular dystrophy, ...

14 January 2022 news dystrophy | gene

Continue Reading →

news

Allogene cleared by FDA to resume ‘off the shelf’ cancer cell therapy trials

The Food and Drug Administration has cleared Allogene Therapeutics to resume testing its cancer cell therapies after determining the company's technology wasn't to bl...

14 January 2022 news Allogene | cancer

Continue Reading →

news

Blueprint, taking aim at larger drugmakers, becomes a biotech buyer

Lengo's drug targets a mutation in the gene that drives production of a protein called EGFR, which, in turn, can help spur tumor growth. The mutation, found in the ex...

3 December 2021 news Biotech | Blueprint

Continue Reading →

news

Mirati gives first look at KRAS drug combination in lung cancer

Mirati's drug, called adagrasib, is particularly closely watched. After Lumakras, which won U.S. approval earlier this year, it's the most advanced experimental drug ...

15 November 2021 news experimental drug | gene

Continue Reading →

news

Vertex aligns with another CRISPR gene editing startup

Mammoth's evolution into a drugmaker appears to be paying off. Three years ago, the company formed with a plan to use CRISPR gene editing to detect and diagnose dise...

29 October 2021 news CRISPR | drugmaker

Continue Reading →

news

Plasticell leads gene therapy manufacturing consortium

UK’s innovation agency provides funding to develop advanced technologies for the manufacturing of autologous ex vivo gene therapies. Plasticell, a developer of st...

29 June 2018 news consortium | gene

Continue Reading →

news

Gene Therapies That Could Transform Diseases Get Easier FDA Path

New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by the Food and Drug Administr...

25 May 2018 news diseases | easier

Continue Reading →

news

Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy

Celonic AG, the Swiss biologics contract development and manufacturing organization, has appointed Soenke Brunswieck as Vice President Cell & Gene Therapy to esta...

8 May 2018 news AG | Brunswieck

Continue Reading →

news

Achieving Large-Scale Cell and Gene Therapy Manufacturing

Initial clinical successes with cell and gene therapies have driven significant investment in these next-generation technologies by both large bio/pharma companies an...

4 May 2018 news achieving | cell

Continue Reading →